Increases in motor speed, volume, and rate of spontaemission tomography (PET) (Davis et al., 1997).
We have now leveraged these observations to investigate neous speech and improved prosody were observed. In addition, changes in both positive and negative afwhether DBS could be used to modulate pathological brain circuits in depression.
fective rating scores (PANAS scale) (Watson and Clark, 1988) occurred coincident with the patients' spontaneWe tested the hypothesis that the use of chronic stimulation to modulate Cg25 gray matter and interconous statements. There were no overt adverse affective or autonomic changes with stimulation at settings pronected frontal and subcortical regions could reverse the pathological metabolic activity in these circuits and ducing these improvements. However, all patients experienced stimulation dose-dependent adverse effects produce clinical benefits in patients with treatmentresistant depression (TRD). This study reports the use including lightheadedness and psychomotor slowing at high settings (over 7.0 Volts), most often seen at the of high-frequency subgenual cingulate white matter (Cg25WM) DBS in six TRD patients. superior electrode contact.
Results

Postoperative Findings: Short-Term Stimulation Effects Patients
Postoperative MR imaging confirmed the placement of All six patients met DSM IV-TR criteria for major dethe DBS electrodes within the subgenual cingulate pressive disorder (MDD) with a major depressive epiwhite matter (Cg25WM) bilaterally as targeted. ( Table 1. negative, increased positive scores) were seen during these stimulation sessions generally using the same contacts and parameters that induced effects in the opIntraoperative Findings DBS electrodes were implanted in Cg25WM under local erating room.
To control for the possibility of a placebo effect, paanesthesia using MR imaging guidance (Figure 1 , row 1: A/B and row 2: C/D) (Schaltenbrand and Wahren, tients were blinded as to which contact was being stim- (Table 2) . By 2 months, five of the six patients met the defined response threshold. Continued antidepressant response was seen in four of these subjects, with some variability up to 5 months. At the 6 month study end- Table 3 ). (patients 1, 3, 5, and 6) and was the first notable sus- tained symptom change. Over the initial few weeks of Control Condition: Blinded DBS Discontinuation We next considered that the long-term benefit in the continuous DBS, increased energy, interest, and psychomotor speed were additionally reported, with efresponders could be related to placebo or nonspecific factors. To examine this possibility, after a period of fects generally appreciable a day or two following stimulation adjustments. Patients and their families decontinuous stimulation for 6 months, the effects of cessation and reintroduction of stimulation was examined scribed renewed interest and pleasure in social and family activities, decreased apathy and anhedonia, as in patient 1, who had shown the earliest, most robust, and best-sustained clinical response (Table 2 ). Followwell as an improved ability to plan, initiate, and complete tasks that were reported as impossible to attempt ing blinded discontinuation of bilateral stimulation (stimulators set at 0.0 V), antidepressant effects were prior to surgery. While all patients continued to report feeling "moderately depressed" for several weeks, sevmaintained for 2 weeks (HDRS = 9; PANAS positive score = 48 of out of a possible 50, PANAS negative eral also indicated that the sensations of "painful emptiness" and "void" remitted almost immediately followscore = 10 out of a possible 50 versus 6 month score positive = 50, negative = 10). In weeks 3 and 4 without ing onset of stimulation at the optimal contacts.
Two patients failed to show a sustained antidepresstimulation, the improvements in mood were also sustained (HDRS = 10). In the context of this sustained eusant response at the 6 month time point (Table 2) DBS). This remission was sustained at 6 weeks of resu- ble 4, left). A similar pattern of hyperactive Cg25 and hypoactive prefrontal cortex was seen in both the DBS responders and nonresponders (data not shown). Responder versus nonresponder differences at baseline were seen primarily in the magnitude of the prefrontal decreases (responders > nonresponders). Responders also showed an area of hyperactivity in the medial frontal cortex (BA10) not seen in the nonresponders; however, the small sample size precluded further analysis. The time course of CBF changes with chronic stimulation of Cg25WM was also examined to establish the relationship of regional brain functioning to behavioral effects. Serial scans were performed after 3 and 6 months in four of the first five patients (1, 2, 3, and 5). Group analyses showed local CBF decreases in Cg25 and adjacent orbital frontal cortex (BA11) after 3 months of stimulation. The long-term responders (patients 1, 3, and 5) showed additional CBF changes at DBS was actually suppressed below that of the controls at both time points, a change also observed in our previous studies of PET scan changes with response to antidepressant medications (Mayberg et al., 2000) . med stimulation at comparable levels to the predisconUnlike medication, brainstem changes were not seen tinuation baseline (HDRS = 4). Taken together, these early with DBS, although changes in the pons were findings suggest that stimulation of Cg25WM produces demonstrated at the 6 month time point. Overall, relong-term improvements in mood that are sustained gional changes seen after 3 months were maintained at beyond the period of active stimulation. The cognitive 6 months in all three responders (Table 4, depressive episode (MDE) before age 35 and had preThe baseline pattern of subgenual cingulate hyperacdominant melancholic features whereas the two nonretivity in combination with frontal hypoactivity described sponders had first episodes in their 40s and had more here in this TRD patient group is a finding that is in atypical symptoms (Table 1) . Differences in electrode contrast to the hypoactivity reported in a more rostral targeting and placement and stimulation parameters region of subgenual medial prefrontal cortex in familial may have also contributed to the observed response bipolar and unipolar depressed patients (Drevets et al.,
variance. The relative contribution of these various 1997). This distinction suggests important differences factors will require testing of additional subjects. In the across subtypes of depression that are potentially relefuture, the possible interactions between DBS and antivant to the pathophysiology of major depressive disordepressant medications need to be examined. ders and perhaps their treatment.
In (Table 3) . Ratings were performed weekly for the first 3 months and were then seen independently by two psychiatrists (V.V. and S.K.) biweekly until the study endpoint at 6 months, following baseline for diagnostic assessment and if potentially eligible, introductory assessments at enrollment and 1 week prior to surgery. Medicdiscussions took place. In all cases, the referring psychiatrist was ations were unchanged throughout the 6 month follow-up period. involved in discussions of the potential benefits and the potential risks associated with DBS. During subsequent meetings with one PET Scanning Acquisition and Data Analysis of the principal investigators (H.S.M.), a family member was invited Regional cerebral blood flow PET scans (rCBF) were acquired preto attend and did so in all cases. Only after these discussions, operatively and after 3 and 6 months of chronic DBS (Fox et al., were interested candidates referred to the neurosurgical principle 1984). Five CBF scans were acquired in each subject at each time investigator (A.L.), who explained the surgical procedure. Interpoint. A comparative scan-set (one time point only) was also acested candidates were offered informed consent forms to read and quired under identical scanning conditions in a group of five agefurther discuss as needed. The average time from initial assessand sex-matched healthy volunteers. All scans were acquired with ment to signing consent was 6-8 weeks.
subjects resting, with eyes closed and no explicit cognitive or motor instructions. Scans were acquired on a GEMS/Scanditronix 2048b camera (15 parallel slices; 6.5 mm center-to-center interslice Surgery distance) using measured attenuation correction (68Ge/68Ga The general surgical procedure for the implantation of DBS transmission scans). rCBF was measured using the bolus [ were then corrected for differences in the whole-brain global mean, the gray and white matters of area 25 were calculated (Figure 1 , and smoothed using a Gaussian kernel to a final in-plane resolution row 2, right).
of 10 mm at full-width at half-maximum. Baseline abnormalities In the operating room under local anesthesia, a burr hole was (patients versus controls) and changes with chronic DBS (3 months drilled 2 cm from the midline in front of the coronal suture. The versus baseline, 6 months versus baseline) were assessed using underlying dura mater was opened, and the exposed pial surface general linear models (peak voxel threshold p = 0.001; cluster coagulated. Tisseal (Immuno, Vienna, Austria) was used to prevent threshold 50 voxels (voxel = 2 mm 
